Navigation Links
Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
Date:2/8/2008

SOUTH SAN FRANCISCO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) will release its fourth quarter and full year 2007 financial results on Thursday, February 14, 2008 after the markets close. The announcement will be followed by a live webcast at 5:00 p.m. ET/ 2:00 p.m. PT, in which Exelixis management will discuss the results and provide a general business update. The webcast may be accessed in the Event Calendar page under Investors at http://www.exelixis.com.

An audio replay of the webcast will be available until 11:59 p.m. ET/ 8:59 p.m. PT on March 15, 2008. Access numbers for the replay are: 1-888-286-8010 (domestic) and 1-617-801-6888, and the passcode is 86315644.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... 18, 2014  Neogen Corporation (Nasdaq: NEOG ... chief operating officer and president, has resigned, effective July ... a consultant going forward on special projects. His resignation ... in this position since September 2013. On an interim ... Herbert , who has been Neogen,s chief executive officer ...
(Date:7/18/2014)... (PRWEB) July 18, 2014 Reflecting the importance ... past ten years, Connie Rankin, the founder and president ... affiliate, recently introduced a fresh new approach to the ... for a Broker to influence the success of his or ... years. CRES was one of the first in this market ...
(Date:7/18/2014)... Nuclear Power Countries - Market Forecast, Key Companies and ... report from GlobalData, Emerging Nuclear Power Countries - Market ... the emerging nuclear market and the key factors affecting ... players and their global market share. The market value ... has also been estimated. , To browse a full ...
(Date:7/18/2014)... Switzerland , July 18, 2014 ... Education in Animal Research for the third consecutive year. ... State University, will attend a 1-week course at Zürich ... of the 3Rs (Replace, Reduce, Refine). As head of ... Popov has been given the task of adapting experimental ...
Breaking Biology Technology:LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2
... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a vaccine-focused ... Yin, Chairman, President and CEO, is scheduled to ... Management Summit,Conference, at Grant Hyatt Beijing Hotel in ... 11th at 1:35 p.m., About Sinovac, ...
... realize the electrical units of voltage, resistance and ... are nowadays used. Important prerequisites are extremely pure ... crystal without collision with residual impurities. To be ... has set up a new molecular beam epitaxy ...
... for Anticipated VentriPoint Diagnostic System Launch, Alpha ... SEATTLE, Aug. 29 VentriPoint Diagnostics,(TSX: VPT) ... discussion and,analysis (MD&A), as well as its unaudited ... 2008, with the Canadian Securities Administrators,through the SEDAR ...
Cached Biology Technology:Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference 2'Racetrack' for fast electrons in semiconductor structures 2VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008 2
(Date:7/21/2014)... seriousness of disease often results from the strength of ... down that response, rather than attacking the virus, might ... Juliet Morrison of the University of Washington, Seattle. She ... in doing just that for the H7N9 influenza, and ... potential therapeutics for this highly virulent strain. The research ...
(Date:7/21/2014)... between songbird species, investigators have found that migration routes ... The research, which is published in Ecology Letters ... the position of a bird and allow its long ... parents, hybrids exhibited increased variability in their migratory routes: ... others used the same routes as one parental group ...
(Date:7/21/2014)... traditional apple orchards, effective management practices rely ... manage competitive vegetation under the trees, and ... factors are further complicated in organic management ... producers need to meet the stringent soil ... the National Organic Program. University of Arkansas ...
Breaking Biology News(10 mins):Potential new flu drugs target immune response, not virus 2Organic apple orchards benefit from green compost applications 2
... American Dietetic Association has published an updated position paper ... calls on schools and communities to work together to ... to promote educational environments that help students learn and ... updated position paper, published in the August issue of ...
... have identified a genetic variant which increases susceptibility to ... as a genome-wide association (GWA) study. This is the ... technique in Africans and demonstrates that such studies are ... of genetic diversity. Over the past few years, ...
... Providing patients with chronic heart failure access to remote ... technology, reduces deaths and hospitalisations and may provide benefits ... are the conclusions of a new Cochrane Systematic Review ... of patients can reduce pressure on resources, particularly for ...
Cached Biology News:Schools, communities share responsibility for child nutrition 2Schools, communities share responsibility for child nutrition 3Genome study identifies genetic variant linked to TB susceptibility in Africans 2Genome study identifies genetic variant linked to TB susceptibility in Africans 3Health care using telephone and telemonitoring technology benefits heart failure patients 2
... The thermostable dUTPase(pyrococcus fruriosus) maximizes the ... DNA polymerases). It removes contaminating ... dNTP solutions. The presence of ... reaction can prevent dUTP misincorporation by ...
... comes with a shutter (controlled via a TTL ... Deuterium Light Source produces a powerful, stable output ... the light source are available, providing a wavelength ... lamp provides peak-to-peak stability of less than 0.005% ...
... The NOVOstar is an exciting product for ... cell-based assays required the use of expensive ... for scientists in the assay development stage. ... for cell-based assays as well as any ...
... intactness and detects events that dissipate ... Benefits: Fast, simple, and ... and for assaying mitochondria intactness ... for the detection of changes in ...
Biology Products: